Drug Discovery and DevelopmentActivities & Teaching Strategies
Active learning deepens understanding of drug discovery by letting students experience the process firsthand. When they role-play trials or map timelines, the abstract stages become concrete, revealing why phased testing matters for safety and reliability.
Learning Objectives
- 1Analyze the stages of drug discovery from initial research to post-market surveillance.
- 2Evaluate the ethical considerations and potential biases present in different phases of clinical trials.
- 3Compare the design and purpose of Phase 1, Phase 2, and Phase 3 clinical trials.
- 4Explain the scientific rationale behind using placebo-controlled, double-blind trials to assess drug efficacy and safety.
- 5Critique the balance between the urgency for new drug approval in public health emergencies and the necessity of rigorous safety testing.
Want a complete lesson plan with these objectives? Generate a Mission →
Role-Play: Mock Clinical Trial
Assign roles as patients, researchers, and regulators. Groups randomise drug or placebo assignments blindly, simulate data collection over two rounds, then reveal allocations to analyse outcomes. Conclude with a debrief on bias reduction. Follow up by having groups present findings to the class.
Prepare & details
Why is the double blind trial considered the gold standard in medical research?
Facilitation Tip: During the Role-Play: Mock Clinical Trial, assign clear roles (researcher, participant, data recorder) to ensure all students engage with the protocol and ethical tensions.
Setup: Flexible space for group stations
Materials: Role cards with goals/resources, Game currency or tokens, Round tracker
Timeline Challenge: Development Stages
Provide cards with key events from discovery to approval. In pairs, sequence them on posters, adding notes on duration, costs, and failures. Pairs then compare timelines and discuss emergency accelerations like COVID vaccines.
Prepare & details
What are the ethical dilemmas involved in testing new drugs on human subjects?
Facilitation Tip: For the Timeline: Development Stages, provide blank templates and key events on cards so students physically sequence them, reinforcing the iterative nature of testing.
Setup: Long wall or floor space for timeline construction
Materials: Event cards with dates and descriptions, Timeline base (tape or long paper), Connection arrows/string, Debate prompt cards
Formal Debate: Ethics in Trials
Divide class into teams to argue for or against rapid drug approval in pandemics. Provide evidence packs on past cases. Teams prepare 3-minute speeches, followed by whole-class voting and reflection on balanced views.
Prepare & details
How can we balance the need for rapid drug approval during emergencies with the need for safety?
Facilitation Tip: In the Debate: Ethics in Trials, give students a structured argument framework (claim, evidence, counterclaim) to guide their reasoning about informed consent and placebo use.
Setup: Two teams facing each other, audience seating for the rest
Materials: Debate proposition card, Research brief for each side, Judging rubric for audience, Timer
Case Study Analysis: Antibiotic Resistance Drug
Small groups receive a real-world case file on a new drug's journey. Chart successes, failures, and ethical decisions. Groups share via gallery walk, noting common trial pitfalls.
Prepare & details
Why is the double blind trial considered the gold standard in medical research?
Facilitation Tip: Use the Case Study: Antibiotic Resistance Drug to highlight how real-world failures inform future designs, asking students to trace a drug’s journey from lab to market failure.
Setup: Groups at tables with case materials
Materials: Case study packet (3-5 pages), Analysis framework worksheet, Presentation template
Teaching This Topic
Teach this topic by grounding abstract concepts in tangible actions. Start with the mock trial to expose students to the unpredictability of human responses, then use the timeline to show how failures shape the process. Avoid rushing to conclusions—let students struggle with uncertainty, as this mirrors the real-world challenges researchers face. Research suggests that when students confront ethical dilemmas directly, their retention of procedural knowledge improves significantly.
What to Expect
Students will explain the purpose and structure of each clinical phase, identify sources of bias in trials, and justify the need for rigorous testing through discussion and evidence. They will also connect ethical considerations to real-world decision-making.
These activities are a starting point. A full mission is the experience.
- Complete facilitation script with teacher dialogue
- Printable student materials, ready for class
- Differentiation strategies for every learner
Watch Out for These Misconceptions
Common MisconceptionDuring Role-Play: Mock Clinical Trial, watch for students assuming that animal test results predict human outcomes perfectly.
What to Teach Instead
Use the mock trial’s debrief to compare animal data sheets with human participant profiles. Ask students to note discrepancies in side effects or reactions, then discuss why these differences emerge.
Common MisconceptionDuring Role-Play: Mock Clinical Trial, watch for students dismissing the need for blinding, assuming participants and researchers will always report honestly.
What to Teach Instead
During the mock trial’s final discussion, demonstrate bias by sharing skewed results from an unblinded trial scenario. Have students identify how expectations influenced outcomes, then correct the data to show blinding’s impact.
Common MisconceptionDuring Timeline: Development Stages, watch for students underestimating the time required for drug development.
What to Teach Instead
Use the timeline activity to overlay real-world timeframes onto student sequences. Ask them to calculate intervals between phases, then compare their estimates to actual averages (e.g., 10-15 years), discussing reasons for delays like failures or regulatory reviews.
Assessment Ideas
After Role-Play: Mock Clinical Trial, prompt a class discussion: 'Identify two reasons why double-blind trials are the gold standard. How do these reasons reduce bias, and what might happen if the trial lacked blinding?' Ask students to reference moments from the role-play where bias could have skewed results.
During Timeline: Development Stages, present students with a scenario: 'A trial enrolls 20 healthy volunteers to test a new painkiller for side effects. Which phase is this, and what is its primary goal?' Ask students to justify their answer using the timeline’s structure and the number of participants.
After Debate: Ethics in Trials, ask students to write one ethical dilemma that arose during the debate and one strategy researchers use to address it. For example, they might describe a participant’s withdrawal of consent and how researchers ensured their data was excluded properly.
Extensions & Scaffolding
- Challenge students to design a Phase 4 post-market surveillance plan for a drug they’ve studied, including monitoring methods and criteria for recall.
- Scaffolding: Provide a partially completed timeline for students who struggle, with key events (e.g., 'FDA approval') missing, so they focus on sequencing the remaining steps.
- Deeper exploration: Have students research a failed drug and present its timeline, analyzing where and why the process broke down, using company reports or regulatory documents.
Key Vocabulary
| Pre-clinical testing | Laboratory and animal studies conducted before human trials to assess a drug's safety and potential efficacy. This stage identifies potential toxicity and determines safe starting doses for human testing. |
| Clinical trials | Research studies involving human volunteers to evaluate the safety and effectiveness of new drugs or treatments. These trials are conducted in distinct phases, each with specific objectives. |
| Placebo | An inactive substance or treatment that looks like the real drug but has no therapeutic effect. Placebos are used in clinical trials to control for psychological effects and establish a baseline for comparison. |
| Double-blind trial | A research study where neither the participants nor the researchers administering the treatment know who is receiving the active drug and who is receiving the placebo. This design minimizes bias in reporting results. |
| Efficacy | The ability of a drug to produce the desired therapeutic effect under ideal or controlled conditions. It measures how well a drug works in clinical trials. |
Suggested Methodologies
Planning templates for Biology
More in Disease and Bio-Security
Pathogens and Transmission
Classifying viruses, bacteria, protists, and fungi and their mechanisms of infection.
2 methodologies
Non-Communicable Diseases
Exploring the causes, risk factors, and prevention of non-infectious diseases like heart disease and cancer.
2 methodologies
First Line Defenses and Non-Specific Immunity
Investigating the body's physical and chemical barriers and the innate immune response.
2 methodologies
The Immune Response: White Blood Cells
Detailing the roles of different types of white blood cells in the body's immune response, including phagocytes and lymphocytes.
2 methodologies
Vaccination and Immunity
Exploring the principles of vaccination, herd immunity, and global health challenges.
2 methodologies
Ready to teach Drug Discovery and Development?
Generate a full mission with everything you need
Generate a Mission